IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 139 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $346,680 | -9.5% | 36,000 | 0.0% | 0.10% | -5.0% |
Q2 2023 | $383,040 | -1.6% | 36,000 | -2.7% | 0.10% | -7.3% |
Q1 2023 | $389,240 | -60.2% | 37,000 | -53.2% | 0.11% | -62.4% |
Q4 2022 | $978,810 | +19.7% | 79,000 | 0.0% | 0.29% | +13.3% |
Q3 2022 | $818,000 | -15.1% | 79,000 | -5.4% | 0.26% | -12.3% |
Q2 2022 | $963,000 | -20.3% | 83,500 | -13.0% | 0.29% | -5.5% |
Q1 2022 | $1,208,000 | +0.7% | 96,000 | -6.7% | 0.31% | +6.9% |
Q4 2021 | $1,200,000 | -35.0% | 102,946 | -27.2% | 0.29% | -41.4% |
Q3 2021 | $1,846,000 | -0.3% | 141,350 | -1.7% | 0.49% | +0.2% |
Q2 2021 | $1,851,000 | +8.8% | 143,850 | -5.4% | 0.49% | +0.4% |
Q1 2021 | $1,701,000 | -4.9% | 152,100 | -3.2% | 0.49% | -7.7% |
Q4 2020 | $1,789,000 | +94.9% | 157,100 | +53.9% | 0.53% | +81.8% |
Q3 2020 | $918,000 | -14.1% | 102,100 | -1.4% | 0.29% | -18.0% |
Q2 2020 | $1,069,000 | +2.3% | 103,600 | 0.0% | 0.36% | -13.8% |
Q1 2020 | $1,045,000 | -30.0% | 103,600 | -7.6% | 0.41% | -14.7% |
Q4 2019 | $1,493,000 | -46.3% | 112,181 | -65.4% | 0.48% | -49.4% |
Q3 2019 | $2,780,000 | -22.8% | 323,872 | -1.6% | 0.96% | -24.1% |
Q2 2019 | $3,602,000 | -3.4% | 329,233 | 0.0% | 1.26% | -5.4% |
Q1 2019 | $3,729,000 | +9.3% | 329,233 | 0.0% | 1.33% | -7.2% |
Q4 2018 | $3,411,000 | -43.9% | 329,233 | 0.0% | 1.44% | -30.4% |
Q3 2018 | $6,078,000 | -15.9% | 329,233 | -12.9% | 2.06% | -21.9% |
Q2 2018 | $7,226,000 | -3.3% | 377,933 | -22.0% | 2.64% | -5.8% |
Q1 2018 | $7,475,000 | +2.4% | 484,465 | -0.5% | 2.80% | +5.2% |
Q4 2017 | $7,301,000 | +220.5% | 487,065 | +237.1% | 2.66% | +224.2% |
Q3 2017 | $2,278,000 | -16.5% | 144,476 | 0.0% | 0.82% | -18.5% |
Q2 2017 | $2,728,000 | +10.7% | 144,476 | 0.0% | 1.01% | +0.4% |
Q1 2017 | $2,465,000 | +11.6% | 144,476 | 0.0% | 1.00% | +5.0% |
Q4 2016 | $2,209,000 | -3.7% | 144,476 | 0.0% | 0.96% | -2.1% |
Q3 2016 | $2,294,000 | +13.3% | 144,476 | -6.5% | 0.98% | +14.9% |
Q2 2016 | $2,024,000 | +19.8% | 154,476 | 0.0% | 0.85% | +16.3% |
Q1 2016 | $1,690,000 | -6.7% | 154,476 | -1.2% | 0.73% | -9.7% |
Q4 2015 | $1,812,000 | +11.2% | 156,345 | 0.0% | 0.81% | +7.6% |
Q3 2015 | $1,629,000 | -13.6% | 156,345 | 0.0% | 0.75% | -6.1% |
Q2 2015 | $1,886,000 | -24.6% | 156,345 | 0.0% | 0.80% | -22.6% |
Q1 2015 | $2,502,000 | +0.6% | 156,345 | -3.7% | 1.04% | -1.5% |
Q4 2014 | $2,487,000 | +15.4% | 162,345 | -2.4% | 1.05% | +9.9% |
Q3 2014 | $2,156,000 | -15.5% | 166,345 | 0.0% | 0.96% | -17.9% |
Q2 2014 | $2,550,000 | +15.1% | 166,345 | -7.5% | 1.17% | +7.3% |
Q1 2014 | $2,216,000 | +2.7% | 179,845 | -3.2% | 1.09% | +1.4% |
Q4 2013 | $2,158,000 | -1.9% | 185,845 | 0.0% | 1.07% | -12.5% |
Q3 2013 | $2,200,000 | +16.7% | 185,845 | -2.1% | 1.23% | +8.9% |
Q2 2013 | $1,885,000 | -45.7% | 189,845 | 0.0% | 1.13% | -45.3% |
Q1 2013 | $3,472,000 | +54.4% | 189,845 | -6.5% | 2.06% | +29.2% |
Q4 2012 | $2,249,000 | – | 202,975 | – | 1.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management, LLC | 6,422,200 | $74,433,000 | 6.49% |
SECTOR GAMMA AS | 1,974,421 | $22,884,000 | 5.88% |
BVF INC/IL | 2,935,975 | $34,028,000 | 5.80% |
Redmile Group, LLC | 3,671,344 | $42,551,000 | 3.18% |
EcoR1 Capital, LLC | 821,531 | $9,522,000 | 2.99% |
BRIDGER MANAGEMENT, LLC | 4,944,594 | $57,308,000 | 1.89% |
Orbimed Advisors | 11,226,400 | $130,114,000 | 1.18% |
Broderick Brian C | 156,345 | $1,812,000 | 0.81% |
Lombard Odier Asset Management (USA) Corp | 602,271 | $6,980,000 | 0.68% |
EverPoint Asset Management, LLC | 2,350,000 | $27,237,000 | 0.57% |